Retraction notice to: Efficacy of Sunitinib and Radiotherapy in Genetically Engineered Mouse Model of Soft-Tissue Sarcoma
Open Access
- 1 July 2009
- journal article
- retracted article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 74 (4) , 1207-1216
Abstract
No abstract availableKeywords
Funding Information
- Howard Hughes Medical Institute
- National Cancer Institute (K12 CA 87723-03, KO8 CA 114176, P50 CA86355, U24 CA92782, U54 CA119349)
- Pfizer
- Radiological Society of North America (P30-CA14051)
- National Comprehensive Cancer Network
This publication has 24 references indexed in Scilit:
- Targeted Deletion of the Calcineurin Inhibitor DSCR1 Suppresses Tumor GrowthCancer Cell, 2008
- TORC1 Is Essential for NF1-Associated MalignanciesCurrent Biology, 2008
- Molecular basis for sunitinib efficacy and future clinical developmentNature Reviews Drug Discovery, 2007
- DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agentsBritish Journal of Cancer, 2007
- Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycinCancer Cell, 2006
- Harnessing preclinical mouse models to inform human clinical cancer trialsJournal of Clinical Investigation, 2006
- Analysis of Hypoxia-Related Gene Expression in Sarcomas and Effect of Hypoxia on RNA Interference of Vascular Endothelial Cell Growth Factor ACancer Research, 2005
- Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3Circulation, 2003
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952